"Lipodystrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
Descriptor ID |
D008060
|
MeSH Number(s) |
C17.800.849.391 C18.452.584.625 C18.452.880.391
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipodystrophy".
Below are MeSH descriptors whose meaning is more specific than "Lipodystrophy".
This graph shows the total number of publications written about "Lipodystrophy" by people in this website by year, and whether "Lipodystrophy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 2 | 0 | 2 |
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2004 | 2 | 2 | 4 |
2005 | 1 | 1 | 2 |
2006 | 2 | 0 | 2 |
2009 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 2 | 1 | 3 |
2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipodystrophy" by people in Profiles.
-
Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy. J Clin Endocrinol Metab. 2023 Dec 21; 109(1):e209-e215.
-
The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges. Orphanet J Rare Dis. 2023 05 26; 18(1):127.
-
Energy expenditure due to gluconeogenesis in pathological conditions of insulin resistance. Am J Physiol Endocrinol Metab. 2021 12 01; 321(6):E795-E801.
-
Ube2i deletion in adipocytes causes lipoatrophy in mice. Mol Metab. 2021 06; 48:101221.
-
Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib. Pediatr Dermatol. 2021 Mar; 38(2):528-529.
-
Leptin decreases de novo lipogenesis in patients with lipodystrophy. JCI Insight. 2020 07 23; 5(14).
-
Free fatty acid processing diverges in human pathologic insulin resistance conditions. J Clin Invest. 2020 07 01; 130(7):3592-3602.
-
Genetic and molecular mechanism for distinct clinical phenotypes conveyed by allelic truncating mutations implicated in FBN1. Mol Genet Genomic Med. 2020 01; 8(1):e1023.
-
Anatomical and Clinical Implications of the Deep and Superficial Fat Compartments of the Neck. Plast Reconstr Surg. 2017 Sep; 140(3):405e-414e.
-
Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review. J Clin Endocrinol Metab. 2017 Feb 01; 102(2):363-374.